Clinical Trial Update: A Study to Evaluate the Safety and Effectiveness of Epoetin Alfa in AIDS (Acquired Immunodeficiency Syndrome) Patients With Anemia Caused Both by Their Disease and by AZT (Zidovudine, an Antiviral Drug) Given as Treatment for Their Disease [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the safety and effectiveness of epoetin alfa in AIDS patients with anemia (caused by both HIV/AIDS and AZT treatment) has been complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acquired Immunodeficiency Syndrome
• Anemia

Drugs mentioned

• EPOETIN ALFA (EPOETIN ALFA)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Anemia, Acquired Immunodeficiency Syndrome | Phase 2 | Status: COMPLETED